Will definitely partner up - SI was asked this question in the webcast following the initial CHF results release and he stated it was too big for MSB and they would negotiate potential partners.
Given the strength of the data, can see the therapy being the standard of care for all heart attack patients in the future - but then I thought that following the initial announcement...
Looking forward to seeing what the Americans do with this tonight
Ann: Rexlemestrocel Reduces Heart Attacks/Strokes/CV Death in CHF, page-117
-
- There are more pages in this discussion • 647 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.0¢ |
Change
0.010(1.02%) |
Mkt cap ! $1.130B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.02 | 98.5¢ | $5.507M | 5.501M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9996 | 99.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.5¢ | 18069 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |